Pressing Pause on Death
NKA Bio is dedicated to developing innovative medicines to enhance critical care and improve patient outcomes. Located in Baltimore, Maryland, NKA Bio focuses on addressing the urgent needs of trauma patients through groundbreaking biotechnology research.
At the forefront of NKA Bio's efforts is NKA01, a temperature-stable antibody designed to provide crucial additional time for severely injured individuals to reach life-saving treatment. This innovative approach aims to bridge the gap between injury and intervention, potentially transforming emergency medical care.
NKA Bio is committed to advancing the field of critical care medicine and improving the lives of patients in need. The company operates primarily from its Baltimore address at 2401 W Belvedere Ave, BioIncubator - Lab 317, Baltimore, Maryland 21215, US. We invite the management team at NKA Bio to enhance this description further with a customized and exclusive company showcase and product listing on our platform.
Compare NKA Bio (Techstars '24) with 3 companies in Biotechnology-Research
| Comparison Field |
NKA Bio (Techstars '24)Main Company |
QuantuMDxView Profile |
Caretaker Medical |...View Profile |
Shock Therapeutics B...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2014 | 2017 |
|
Company Size
|
— | 51-200 | 11-50 | 2-10 |
|
City
|
Baltimore, Maryland | Newcastle upon Tyne, Tyne and Wear | Charlottesville, Virginia | Baltimore, Maryland |
|
Country
|
United States | United Kingdom | United States | United States |
|
Skills & Keywords
Comparing with main company
|
26 Total Skills
Biotechnology
Pharmaceuticals
Antibody Engineering
Trauma Care
Critical Care
Emergency Medicine
Drug Development
Acute Lung Injury
Phage Display
ARDS
Combat Casualty Care
Hemorrhage Resuscitation
Sepsis
Septic Shock
Hemorrhagic Shock
Bacterial Sepsis
Trauma Resuscitation
TCCC
In Silico Drug Design
Heart Attack
Trauma Surgery
Acute Care Surgery
Military Medicine
Assay Development
ICU
Cardiogenic Shock
|
19 Total
19 Unique
Unique Skills:
Assay Feasibility
COVID-19
Diagnostic device
DNA extraction
Host Response
In vitro Diagnostics
+13
|
19 Total
19 Unique
Unique Skills:
Blood Pressure
Cardiology
cardiovascular
Continuous cardiac output
Continuous Non-Invasive Blood Pressure
Critical care
+13
|
9 Total
1 Common
8 Unique
Match
4%
Common Skills:
Biotechnology
Unique Skills:
Antibody Development
Biomedical Engineering
Cardiology
Endocronology
Immunology
Infectious Disease
+2
|
Other organizations in the same industry
This company is also known as